Materialise/$MTLS
1D1W1MYTD1Y5YMAX
Capital at risk
About Materialise
Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.
- Ticker
- $MTLS
- Sector
- Software & Cloud Services
- Primary listing
- NASDAQ
- Employees
- 2,556
- Headquarters
- Leuven, Belgium
- Website
- www.materialise.com
Materialise Metrics
BasicAdvanced
$492M
33.65
$0.25
1.36
-
Price and volume
Market cap
$492M
Beta
1.36
52-week high
$8.82
52-week low
$4.78
Average daily volume
200K
Financial strength
Current ratio
2.406
Quick ratio
2.065
Long term debt to equity
0.196
Total debt to equity
0.232
Interest coverage (TTM)
5.33%
Profitability
EBITDA (TTM)
27.059
Gross margin (TTM)
57.23%
Net profit margin (TTM)
4.84%
Operating margin (TTM)
2.99%
Effective tax rate (TTM)
1.61%
Revenue per employee (TTM)
$123,770
Management effectiveness
Return on assets (TTM)
1.24%
Return on equity (TTM)
5.22%
Valuation
Price to earnings (TTM)
33.649
Price to revenue (TTM)
1.629
Price to book
1.93
Price to tangible book (TTM)
2.61
Price to free cash flow (TTM)
25.324
Free cash flow yield (TTM)
3.95%
Free cash flow per share (TTM)
0.336
Growth
Revenue change (TTM)
2.72%
Earnings per share change (TTM)
149.23%
3-year revenue growth (CAGR)
2.72%
10-year revenue growth (CAGR)
9.69%
3-year earnings per share growth (CAGR)
182.04%
10-year earnings per share growth (CAGR)
14.08%
What the Analysts think about Materialise
Analyst ratings (Buy, Hold, Sell) for Materialise stock.
Analyst projections of the future price of Materialise stock.
Bulls say / Bears say
Medical remains the strongest growth engine: Q2 Medical revenue rose 12.2%, with medical devices and services up 19%, and the segment produced a 31% adjusted EBITDA margin. (Materialise, MarketBeat)
Profitability and cash generation are improving: first-half free cash flow reached €11.4m, net cash rose to €74.2m, and management raised full-year adjusted EBIT guidance to €12m–€14m. (Materialise, StockTitan)
The manufacturing turnaround is gaining traction: Q2 revenue rose 6.7%, aerospace revenue grew 40%, and the segment’s adjusted EBITDA loss narrowed to €0.3m from €0.8m a year earlier. (3DPrint.com, MarketBeat)
Software remains under pressure: Q2 revenue fell 2.7% as cautious customer spending and longer sales cycles weighed on demand. (Materialise, The Motley Fool)
The overall growth outlook is still modest: first-half revenue rose only 3.9%, while full-year revenue guidance stayed at €273m–€283m despite the improved profit forecast. (Materialise, 3DPrint.com)
Underlying earnings remain relatively thin: Q2 adjusted EBIT was €3.9m on €70.1m of revenue, while the reported net profit was helped by a better net financial result and a tax benefit. (Materialise, Exa)
Data summarised monthly by Lightyear AI. Last updated on 23 Sept 2026.
Materialise Financial Performance
Revenues and expenses
Materialise Earnings Performance
Company profitability
Upcoming events
No upcoming events
Materialise News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.